Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
09/2003
09/03/2003CN1439651A Recombined human CD11a monoclone antibody and its preparation and medicinal composition
09/03/2003CN1439647A Saltant dihydrofolic acid reductase gene and application in mammal cell gene expression thereof
09/03/2003CN1439426A Medicine composition and preparation and use thereof
09/03/2003CN1120173C Antitumor substance extracted from Grifola
09/02/2003US6613962 Given DNA sequence; insect resistance
09/02/2003US6613891 Polynucleotides that encode bovine inhibin
09/02/2003US6613746 Cell adhesion proteins having cells with glycoprotein antibodies and carbohydrate determinants used to interfere with binding FC receptor and as complement inhibitors; antiinflammatory agents
09/02/2003US6613738 Comprising 1,2-dihydroxy-homotyrosine, 4-hydroxyproline, threonine, glutamine, 3-,4-dihydroxymethylproline, 4,5-dihydroxyornithine and lipid
09/02/2003US6613574 Method to identify interface residue in biomolecular complex
09/02/2003US6613548 Fusion products containing insoluble proteinaceous tag
09/02/2003US6613547 Nucleotides; signal sequences; DNA sequences; Saccharomyces; vectors/genetic/; yeasts; proteins; use of recombinant DNA containing transcription sequences in the production of proteins of interest
09/02/2003US6613544 Osteoprotegerin
09/02/2003US6613521 Nucleic acids; CARD (Caspase Recruitment Domain) proteins; primers; hybridization probes; use in diagnosis, therapy for disorders from with abnormal levels of apoptotic cell death or abnormal activity of FAS/APO-1 or TNF receptor complexes
09/02/2003US6613514 Evolving preferential protein; digest nuclelotide sequences substrate, join terminals, screen for preferential proteins, recover nucleotide sequences
09/02/2003US6613331 Vaccine against Lyme disease
09/02/2003US6613328 Methods of treating thrombotic diseases with von Willebrand factor specific antibodies
08/2003
08/28/2003WO2003070981A2 Seequences specifically deleted mycobacterium tuberculosis genome and their use in diagnostics and as vaccines
08/28/2003WO2003070965A2 The eaat2 promoter and uses thereof
08/28/2003WO2003070961A1 Chimeric cannulae proteins, nucleic acids encoding them and methods for making and using them
08/28/2003WO2003070954A1 Transcriptional factor, transcriptional factor gene, recombinant vector containing transcriptional factor gene, koji-mold transformed by the vector and method of using koji-mold
08/28/2003WO2003070937A1 Protein having osteogenic protein-binding region and gene encoding the same
08/28/2003WO2003070889A2 Prostate specific genes and the use thereof in design or therapeutics
08/28/2003WO2003070880A2 Bacteria with reduced genome
08/28/2003WO2003070771A1 Rrp sequences and knockout mice and uses thereof
08/28/2003WO2003070765A2 Growth hormone fusion protein
08/28/2003WO2003070760A2 Anti-amyloid beta antibodies and their use
08/28/2003WO2003070756A2 Novel glycopeptide antibiotics and method for synthesis thereof
08/28/2003WO2003070752A2 Mhc-peptide complex binding ligands
08/28/2003WO2003070740A1 RIBOZYMES WITH BROAD tRNA AMINOACYLATION ACTIVITY
08/28/2003WO2003070192A2 Compositions and methods for surrogate antibody modulation of an immune response and transport
08/28/2003WO2003070190A2 Surrogate antibodies and methods of preparation and use thereof
08/28/2003WO2003055911A3 Cystine-knot fold protein
08/28/2003WO2003053158A3 Malleable protein matrix and uses thereof
08/28/2003WO2003043986A8 Polypeptides of moraxella (branhamella) catarrhalis
08/28/2003WO2003025183A3 Random integration of a polynucleotide after in vivo linearization
08/28/2003WO2003020912A3 Novel clark protein and nucleic acid molecules and uses therefor
08/28/2003WO2003020894A3 Insulin related transcription factor and uses thereof
08/28/2003WO2003018631A3 Nogo receptor homologues and their use
08/28/2003WO2003016522A3 Methods and compounds for the targeting of protein to exosomes
08/28/2003WO2003014161A3 Antigen binding domains from fish
08/28/2003WO2003012114A3 Methods of rna and protein synthesis
08/28/2003WO2002102990A3 Fibroblast growth factor and nucleic acid encoding same
08/28/2003WO2002097051A3 Protein arrays and methods and systems for producing the same
08/28/2003WO2002097044A3 Alternative splice forms of proteins as basis for multiple therapeutic modalities
08/28/2003WO2002078603A3 Plasmodium falciparum erythrocyte binding protein baebl for use as a vaccine
08/28/2003WO2002074783A3 Modified interferon beta with reduced immunogenicity
08/28/2003WO2002070006A3 Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses
08/28/2003WO2002068469A3 Modified thrombopoietin with reduced immunogenicity
08/28/2003WO2002046749A3 Screening method for identifying compounds that selectively induce interferon alpha
08/28/2003WO2002044736A3 Diagnosis and treatment of epidermal or skin diseases
08/28/2003WO2002043478A3 Transgenic transchromosomal rodents for making human antibodies
08/28/2003WO2002036627A3 Interferons, uses and compositions related thereto
08/28/2003WO2002012326A3 Mechanism of conditional regulation of the hypoxia-inducible factor-1 by the von hippel-lindau tumor suppressor protein
08/28/2003WO2002008399A3 Human kinases
08/28/2003WO2001096875A3 Hcv antigen/antibody combination assay
08/28/2003US20030163845 Elongase genes and uses thereof
08/28/2003US20030162954 Antitumor agents; gastrointestinal disorders
08/28/2003US20030162947 Rapid production of monoclonal antibodies
08/28/2003US20030162946 Isolated human G-protein coupled receptors, nucleic acid molecules encoding human GPCR proteins, and uses thereof
08/28/2003US20030162944 Nucleic acid encoding neuropeptide Y/peptide YY (Y2) receptors and uses thereof
08/28/2003US20030162736 Medicament comprising NK4 gene or recombinant NK4 protein
08/28/2003US20030162718 Antigrowth agents; microbiocides, bactericides
08/28/2003US20030162709 Methods of generating multispecific, multivalent agents from VH and VL domains
08/28/2003US20030162279 22438, 23553, 25278, and 26212 novel human sulfatases
08/28/2003US20030162274 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
08/28/2003US20030162260 Fusion proteins that includes an immune enhancing domain and an immunogenic domain
08/28/2003US20030162256 PTH1R and PTH3R receptors, methods and uses thereof
08/28/2003US20030162250 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/28/2003US20030162249 Providing a culture of bacterial cells, adding rhanmose to the culture to induce rhamnose promoter whereby the antibody heavy chain and light chain and their linked signal sequences are expressed, secreted to the periplasm
08/28/2003US20030162246 Using a diffusion continuous batch system including synthesis reaction mixture containing a biological extract and a supply solution containing substrate and energy source, contacting both to form cell-free protein, removing by-product
08/28/2003US20030162176 Complementary DNAs
08/28/2003US20030162175 NK cell receptor polynucleotides, polypeptides, and antibodies
08/28/2003US20030161837 Crosslinking an immunoglobulin or fragment thereof with anN-hydroxyl-succinimide ester and a maleimide linked vis a polyethyleneoxide spacer and incubating with a polypeptide having a sulfhydryl group (an allergen or autoantigen)
08/28/2003US20030161836 Biological materials and methods useful in the diagnosis and treatment of diseases
08/28/2003US20030161833 Chlamydia antigens and corresponding DNA fragments and uses thereof
08/28/2003CA2477195A1 Deleted sequence in m. tuberculosis, method for detecting mycobacteria using these sequences and vaccines
08/28/2003CA2477012A1 Anti-a.beta. antibodies and their use
08/28/2003CA2476854A1 Surrogate antibodies and methods of preparation and use thereof
08/28/2003CA2476764A1 Compositions and methods for surrogate antibody modulation of an immune response and transport
08/28/2003CA2476625A1 Mhc-peptide complex binding ligands
08/28/2003CA2476362A1 Chimeric cannulae proteins, nucleic acids encoding them and methods for making and using them
08/28/2003CA2473922A1 Bacteria with reduced genome
08/28/2003CA2473133A1 Rrp sequences and knockout mice and uses thereof
08/27/2003EP1338657A1 Sequences specifcally deleted from Mycobacterium tuberculosis genome and their use in diagnosistics and as vaccines
08/27/2003EP1338649A1 Novel gene overexpressed in heart and skeletal muscle and use tehreof
08/27/2003EP1338607A2 Antigenic iron repressible proteins from n. meningitidis related to the heolysin family of toxins
08/27/2003EP1337651A2 Promoter for the functional characterisation of g-protein coupled receptors in the yeast saccharomyces cerevisiae
08/27/2003EP1337641A2 Flea gaba receptor subunit nucleic acid molecules, proteins and uses thereof
08/27/2003EP1337640A2 NOVEL RETINA-SPECIFIC HUMAN PROTEINS C7orf9, C12orf7, MPP4 AND F379
08/27/2003EP1337638A2 Adipocyte complement related protein zacrp13
08/27/2003EP1337636A2 Soluble zcytor 11 cytokine receptors
08/27/2003EP1337634A2 Novel polypeptides involved in immune response
08/27/2003EP1337558A2 A "bach" g protein coupled receptor polypeptide and polynucleotide encoding this receptor
08/27/2003EP1337552A2 Light-driven energy generation using proteorhodopsin
08/27/2003EP1337543A1 Streptavidin-binding peptides and uses thereof
08/27/2003EP1337152A2 Methods of utilizing cultured non-gvhd inducing t lymphocytes to treat disease
08/27/2003EP1337149A2 Vaccine immunotherapy for immune suppressed patients
08/27/2003EP1110086A4 Production of motif-specific and context-independent antibodies using peptide libraries as antigens
08/27/2003EP0932625B1 Monoclonal antibodies against the ypydvpdya epitope, process for producing the same and their use
08/27/2003EP0909277B1 Humanized antibodies that bind to the same antigen as bound by antibody nr-lu-13, and their use in pretargeting methods
1 ... 566 567 568 569 570 571 572 573 574 575 576 577 578 579 580 581 582 583 584 585 586 ... 1125